Xvivo Perfusion
XVIVO | ST
Overview
Corporate Details
- ISIN(s):
- SE0004840718 (+1 more)
- LEI:
- 549300G2464FYLS14B41
- Country:
- Sweden
- Address:
- Gemenskapens Gata 9, 431 53 Mölndal
- Website:
- https://www.xvivoperfusion.com/
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
XVIVO is a medical technology company with headquarter in Gothenburg, Sweden, a production site in Lund, Sweden and office in Denver, USA. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 20 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-28 22:10 |
Regulatory News Service
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
|
Swedish | 64.3 KB | |
| 2025-07-28 22:10 |
Regulatory News Service
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
|
English | 63.6 KB | |
| 2025-07-11 07:30 |
Earnings Release
|
Swedish | 2.0 MB | |
| 2025-07-11 07:30 |
Earnings Release
|
English | 2.0 MB | |
| 2025-04-25 14:25 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
|
Swedish | 59.6 KB | |
| 2025-04-25 14:25 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
|
English | 60.1 KB | |
| 2025-04-24 07:30 |
Earnings Release
|
Swedish | 1.9 MB | |
| 2025-04-24 07:30 |
Interim Report
|
English | 6.8 MB | |
| 2025-03-20 17:45 |
General Meeting Notice
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
|
English | 111.0 KB | |
| 2025-03-20 17:45 |
General Meeting Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
|
Swedish | 108.6 KB | |
| 2025-01-28 07:30 |
Earnings Release
|
Swedish | 1.2 MB | |
| 2025-01-28 07:30 |
Earnings Release
|
English | 1.2 MB | |
| 2024-12-02 10:46 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 8.3 KB | |
| 2024-10-24 07:30 |
Earnings Release
|
Swedish | 1.2 MB | |
| 2024-10-24 07:30 |
Earnings Release
|
English | 1.2 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-24 | Dag Andersson Tilk | Other | Other | 5,417 | 1,115,251.96 SEK |
| 2022-05-20 | Dag Andersson Tilk | Other | Buy | 135 | 33,986.25 SEK |
| 2022-05-03 | Dag Andersson Tilk | Other | Buy | 500 | 108,000.00 SEK |
| 2022-01-31 | Dag Andersson Tilk | Other | Buy | 384 | 99,840.00 SEK |
| 2021-12-21 | Lena Höglund | Other | Buy | 1,300 | 327,847.00 SEK |
| 2021-11-25 | Dag Andersson Tilk | Other | Buy | 25 | 7,087.50 SEK |
| 2021-11-25 | Dag Andersson Tilk | Other | Buy | 473 | 133,617.77 SEK |
| 2021-11-10 | Dag Andersson Tilk | Other | Buy | 325 | 104,774.00 SEK |
| 2021-09-10 | Dag Andersson Tilk | Other | Buy | 676 | 299,130.00 SEK |
| 2021-08-30 | Dag Andersson Tilk | Other | Buy | 348 | 148,944.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1SPATIAL PLC | United Kingdom | SPA | |
|
aap Implantate AG | Germany | AAQ1 | |
|
ABL Diagnostics | France | ABLD | |
|
AddLife | Sweden | ALIF | |
|
Aiforia Technologies Oyj | Finland | AIFORI | |
/other/Aino_Health_AB_publ-logo.png){kind=logo}
|
Aino Health AB (publ) | Sweden | AINO | |
|
Almirall S.A. | Spain | ALM | |
|
AMA Corporation PLC Corporation | United Kingdom | ALAMA | |
|
Amplifon | Italy | AMP | |
|
Amplitude Surgical | France | AMPLI |